CarMax Inc: Exane BNP Paribas raises target price to $48 from $33
KMX•Exane BNP Paribas raised its target price for CarMax to $48 from $33.
Related News

Moderna appoints Juan Andres as chief operating officer
MRNA•

Beamr Imaging expects FY2026 revenue of $4.50 million, up 50% over FY2025
BMR•

Aqua Pennsylvania acquires Ulster Municipal Authority water system in Bradford County
WTRG•

Rafael Holdings says Phase 3 TransportNPC trial of Trappsol Cyclo misses primary endpoint in Niemann-Pick type C
RFL•

Kailera Therapeutics completes enrollment in global Phase 3 ribupatide program
KLRA•